Ovarian Reserve Tests

Overview

Journal J Hum Reprod Sci

Date 2012 Feb 21

PMID 22346076

Citations 30

Authors

Padma Rekah Jirge

Affiliations

Soon will be listed here.

Abstract

Ovarian reserve plays a crucial role in achieving pregnancy following any treatment in subfertile women. The estimation of ovarian reserve is routinely performed through various ovarian reserve tests (ORTs) in an effort to predict the response and outcome in couples prior to In Vitro Fertilization and counsel them. Most widely used tests are basal follicle stimulating hormone and anti-Mullerian hormone and antral follicle count. The role of ORTs in our routine practice is discussed in this article. A MEDLINE search was done to identify suitable articles for review.

Citing Articles

Environmental Exposure to Per- and Polyfluorylalkyl Substances (PFASs) and Reproductive Outcomes in the General Population: A Systematic Review of Epidemiological Studies.

Haimbaugh A, Meyer D, Connell M, Blount-Pacheco J, Tolofari D, Gonzalez G Int J Environ Res Public Health. 2025; 21(12.

PMID: 39767456 PMC: 11675763. DOI: 10.3390/ijerph21121615.

The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis.

Salemi F, Jambarsang S, Kheirkhah A, Salehi-Abargouei A, Ahmadnia Z, Hosseini H Syst Rev. 2024; 13(1):303.

PMID: 39695880 PMC: 11657140. DOI: 10.1186/s13643-024-02684-0.

'Age specific variations in ovarian reserves in healthy fertile and infertile women: A cross sectional study.

Malhotra N, Gupta P, Kamboj S, Chaturvedi P, Kutum R PLoS One. 2024; 19(10):e0308865.

PMID: 39446778 PMC: 11500972. DOI: 10.1371/journal.pone.0308865.

GnRH agonist early follicular challenge test as a predictor of ovarian response in antagonist cycles for fertility preservation.

Yerushalmi G, Avraham S, Kedem A, Youngster M, Barkat J, Baruchin O Sci Rep. 2024; 14(1):14308.

PMID: 38906914 PMC: 11192755. DOI: 10.1038/s41598-024-65059-4.

Uncovering the impact of alcohol on internal organs and reproductive health: Exploring TLR4/NF-kB and CYP2E1/ROS/Nrf2 pathways.

Kong E, Subramaniyan V, Lubau N Animal Model Exp Med. 2024; 7(4):444-459.

PMID: 38853347 PMC: 11369036. DOI: 10.1002/ame2.12436.

References

Penarrubia J, Fabregues F, Manau D, Creus M, Casals G, Casamitjana R . Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Hum Reprod. 2005; 20(4):915-22. DOI: 10.1093/humrep/deh718. View

Maheshwari A, Fowler P, Bhattacharya S . Assessment of ovarian reserve--should we perform tests of ovarian reserve routinely?. Hum Reprod. 2006; 21(11):2729-35. DOI: 10.1093/humrep/del188. View

Lass A, Silye R, Abrams D, Krausz T, Hovatta O, Margara R . Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod. 1997; 12(5):1028-31. DOI: 10.1093/humrep/12.5.1028. View

Chuang C, Chen C, Chao K, Chen S, Ho H, Yang Y . Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003; 79(1):63-8. DOI: 10.1016/s0015-0282(02)04562-4. View

Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri D, Serhal P . Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. BJOG. 2005; 112(10):1384-90. DOI: 10.1111/j.1471-0528.2005.00670.x. View

Sharif K, Elgendy M, Lashen H, Afnan M . Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol. 1998; 105(1):107-12. DOI: 10.1111/j.1471-0528.1998.tb09360.x. View

Seifer D, Scott Jr R, Bergh P, Abrogast L, Friedman C, Mack C . Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril. 1999; 72(1):63-5. DOI: 10.1016/s0015-0282(99)00193-4. View

Nikolaou D, Templeton A . Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod. 2003; 18(6):1137-9. DOI: 10.1093/humrep/deg245. View

Frattarelli J, Bergh P, Drews M, Sharara F, Scott R . Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril. 2000; 74(3):518-24. DOI: 10.1016/s0015-0282(00)00693-2. View

10.

Toner J, Philput C, Jones G, Muasher S . Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991; 55(4):784-91. DOI: 10.1016/s0015-0282(16)54249-6. View

11.

Ficicioglu C, Kutlu T, Baglam E, Bakacak Z . Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006; 85(3):592-6. DOI: 10.1016/j.fertnstert.2005.09.019. View

12.

Jarvela I, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G . Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol. 2003; 102(4):816-22. View

13.

van Rooij I, Broekmans F, Scheffer G, Looman C, Habbema J, de Jong F . Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83(4):979-87. DOI: 10.1016/j.fertnstert.2004.11.029. View

14.

Higgins R, van Nagell Jr J, Woods C, Thompson E, Kryscio R . Interobserver variation in ovarian measurements using transvaginal sonography. Gynecol Oncol. 1990; 39(1):69-71. DOI: 10.1016/0090-8258(90)90401-6. View

15.

Scott Jr R, Hofmann G, Oehninger S, Muasher S . Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril. 1990; 54(2):297-302. DOI: 10.1016/s0015-0282(16)53707-8. View

16.

Bancsi L, Broekmans F, Looman C, Habbema J, Te Velde E . Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril. 2004; 81(1):35-41. DOI: 10.1016/j.fertnstert.2003.06.011. View

17.

Nelson S, Yates R, Lyall H, Jamieson M, Traynor I, Gaudoin M . Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009; 24(4):867-75. DOI: 10.1093/humrep/den480. View

18.

Hendriks D, Broekmans F, Bancsi L, Looman C, de Jong F, Te Velde E . Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet. 2005; 22(2):65-73. PMC: 3455479. DOI: 10.1007/s10815-005-1495-3. View

19.

Nelson S, Messow M, Michael Wallace A, Fleming R, McConnachie A . Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients. Fertil Steril. 2010; 95(2):736-41.e1-3. DOI: 10.1016/j.fertnstert.2010.08.022. View

20.

Licciardi F, Liu H, Rosenwaks Z . Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995; 64(5):991-4. DOI: 10.1016/s0015-0282(16)57916-3. View